Skip to main content
Last Updated
Case Status
Federal Trade Commission, Plaintiff, v. Neurometrix, a Delaware corporation; and Shai Gozani, individually and as an officer of Neurometrix, Inc.; Defendants.
FTC Matter/File Number
172 3130
Civil Action Number
Federal Court
District of Massachusetts

Case Summary

Under a settlement with the Federal Trade Commission announced in March 2020, the marketers of an electrical nerve stimulation device called Quell have agreed to pay $4 million and stop making deceptive claims that the device treats pain throughout the body when placed below the knee. They also will stop claiming the device’s efficacy is clinically proven and that it has been cleared by the FDA to treat pain throughout the body. In early September 2020, the FTC announced it was returning almost $3.9 million to defrauded consumers.